Vimarsana
Biggest News Aggregation in the World

Axel Kock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Axel Kock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Axel Kock Today - Breaking & Trending Today

CSL Seqirus Transitions to Trivalent Influenza Vaccines: Insights From Chief Health Officer Gregg Sylvester, MD - Vimarsana News

CSL Seqirus Transitions to Trivalent Influenza Vaccines: Insights From Chief Health Officer Gregg Sylvester, MD

Discover the considerations behind CSL Seqirus' shift to trivalent influenza vaccines, removing B/Yamagata strain. Gregg Sylvester, MD, MPH, explains the impact on effectiveness and steps for a seamless transition in health care facilities.

Breast Cancer Incidence Highest Among Young Black Women in the US - Vimarsana News

Breast Cancer Incidence Highest Among Young Black Women in the US

Researchers have identified a surge in breast cancer rates among young women and racial disparities across age groups.

Source: ajmc.com
Expert: Pharmacists Play Key Role in Culturally Competent Care for Racially Diverse Patients - Vimarsana News

Expert: Pharmacists Play Key Role in Culturally Competent Care for Racially Diverse Patients

Mara Hofherr, PharmD, a clinical oncology pharmacist at Washington University, highlights key findings of the KEYNOTE-522 trial in comparison of outcomes between Black and White patients with triple-negative breast cancer.

Lack of Vitamin D May Increase Chemo-Induced Neuropathy Risk in Breast Cancer - Vimarsana News

Lack of Vitamin D May Increase Chemo-Induced Neuropathy Risk in Breast Cancer

Investigators note that prospective research is needed to confirm the efficacy of vitamin D supplements in preventing chemotherapy-induced peripheral neuropathy in patients with breast cancer.

Source: ajmc.com
Expert: Combination of Lenvatinib, Pembrolizumab Outperformed Sunitinib in the Treatment of Advanced RCC - Vimarsana News

Expert: Combination of Lenvatinib, Pembrolizumab Outperformed Sunitinib in the Treatment of Advanced RCC

Viktor Grunwald, MD, PhD, discusses the post-hoc analysis of the phase 3 CLEAR trial investigating the combination treatment in the first-line setting for advanced renal cell carcinoma.